hero ornaments hero ornaments

What’s New at Arkin

Stay informed with our latest updates, news, and events

Investment Activity:

  • All

  • Bio

  • Capital

  • Digital Health

  • Foundry

News

cCAM Biotherapeutics receives FDA approval to initiate phase One trial for CM-24, a novel immune checkpoint inhibitor for cancer immunotherapy

Read more
News
Blog & Newsletter
Events
Previous
Next